Alzheimer disease in the US population: prevalence estimates using the 2000 census.

By L. Hebert, P. Scherr, Julia L. Bienias, David A. Bennett, Denis A. Evans. Archives of Neurology, 2003

2,364 citations recorded by the source corpus.

Subfields: Molecular Biology, Physiology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/1ee0bb36eab80691266eba3ace2fbb6ce12195bf

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

In Physiology

In Psychiatry and Mental health

Citations in the corpus

The Role of the Anaphylatoxins in Health and Disease (2009, neutral): “5 million individuals in the US alone afflicted with the disease, most above the age of 65 (Hebert et al., 2003).”
Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease (2004, background): “Although AD accounts for most of age-related dementia (34), AD is also clinically and neuropathologically similar to other forms of dementia, for example, vascular dementia (VaD).”
A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease (2010, background): “5 million Americans suffer with AD, and these numbers are expected to nearly triple by the year 2050.(64) Approved treatments are directed at modulating neurotransmission in general and are not regionally targeted or specific.”
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention (2009, background): “2 million.(33) The more recent study indicated that in 2006 the worldwide total number of patients with AD was 26.”
The Global Demography of Aging: Facts, Explanations, Future (2016, positive): “Projections suggest that the prevalence of Alzheimer’s will more than triple in the next few decades in the United States (Brookmeyer et al., 1998; Hebert et al., 2003).”
Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship (2009, background): “Epidemiological studies indicate that clinical AD prevalence doubles every half decade after age 65 years so that approximately 25% of 90-year-olds carry the diagnosis of AD (15, 16).”
Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study (2007, background): “5 million.[5,26] The lowest estimate came from a meta-analysis of 18 US and European studies; the highest from the East Boston and Chicago community studies.”
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census (2013, result): “DISCUSSION Updating each of the 5 components of the analyses produces results consistent with the previously reported AD projections using the 2000 census population projections.(1) Statistically, they are comparable, and, more importantly, both old and new estimates continue to show that the burden”
2016 Alzheimer's disease facts and figures (2016, positive): “Census suggest that this number may be as high as 16 million [179].”
Intelligent Technology for an Aging Population: The Use of AI to Assist Elders with Cognitive Impairment (2005, background): “[Hebert et al.2003] Hebert, L. E.; Scherr, P. A.; Bienias, J. L.; Bennett, D.; and Evans, D. A. 2003.”
Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences (2014, positive): “be diagnosed with the disease by 2050 unless new treatments to prevent or delay the onset of AD are identified.(3,4) Women are disproportionally affected by AD; they are”